Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial
Abstract
We wished to determine whether the Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R) is reliable when used as primary outcome measure in a multicenter clinical trial. To establish inter-rater reliability, we randomly assigned 19 primary raters and 11 back-up raters to score nine amyotrophic lateral sclerosis (ALS) patients using the ALSFRS-R. To assess intra-rater reliability and reliability of telephone administration, we randomly assigned consecutive participants of the Clinical Trial of High Dose Coenzyme Q10 in ALS (QALS) to have in-person ALSFRS-R interviews at both screening and baseline visits (n=41 patients) or to have the ALSFRS-R interview by telephone at screening and in person at the baseline visit (n=27). An intraclass correlation coefficient (ICC) of reliability was calculated using a one-way random effects analysis of variance model. In the inter-rater reliability assessment, the primary raters performed 54 ratings on nine patients with ICC=0.93 (95% CI 0.84-0.98). For back-up raters, 32 ratings on nine patients resulted in ICC=0.93 (95% CI 0.82-0.98). The intra-rater reliability for in-person interviews was ICC = 0.95 (95% CI 0.92-0.98). The reliability of telephone administration compared to in-person interviews was ICC=0.97 (95% CI 0.93-0.98). We conclude that the ALSFRS-R shows excellent inter- and intra-rater reliability, and reliability of telephone administration when used as primary outcome measure in a multicenter ALS trial.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Administration of ALSFRS-R by trained non-clinicians has been demonstrated to have exemplary inter-rater, intra-rater, and telephone-administered reliability.
“The administration of the ALSFRS-R by trained non-clinicians has been demonstrated to have exemplary inter-rater, intra-rater, and telephone-administered reliability (21).”
From Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort (2018) · cites this paper as [21]
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 23,433 · see citing works
The Design and Analysis of Clinical Experiments
Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819 · see citing works
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307 · see citing works
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,239 · see citing works
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V., Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,303 · see citing works
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 453 · see citing works
ALS CNTF Treatment Study Group (1996) · Neurology · doi:10.1212/wnl.46.5.1244 · Cited by 405 · see citing works
Effect of recombinant human insulin-like growth factor-I on progression of ALS
Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361 · see citing works
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H. J., Dobbins, T., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.583 · Cited by 339 · see citing works
A clinical trial of creatine in ALS
Shefner, J. M., Cudkowicz, M., Schoenfeld, D., Conrad, T. M., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142992.81995.f0 · Cited by 293 · see citing works
Self-citationCedarbaum, J. M., & Stambler, N. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00237-2 · Cited by 284 · see citing works
A randomized sequential trial of creatine in amyotrophic lateral sclerosis
Groeneveld, G. J., Veldink, J. H., van der Tweel, I., Kalmijn, S., Beijer, C., de Visser, M., Wokke, J. H. J., Franssen, H., & van den Berg, L. H. (2003) · Annals of Neurology · doi:10.1002/ana.10554 · Cited by 283 · see citing works
The ALSFRSr predicts survival time in an ALS clinic population
Kaufmann, P., Levy, G., Thompson, J. L. P., DelBene, M., Battista, V., Gordon, P. H., Rowland, L. P., Levin, B., & Mitsumoto, H. (2005) · Neurology · doi:10.1212/01.wnl.0000148648.38313.64 · Cited by 243 · see citing works
Self-citationPhase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
Miller, R. G., Moore, D. H., Gelinas, D. F., Dronsky, V., Mendoza, M., Barohn, R. J., Bryan, W. W., Ravits, J., Yuen, E., Neville, H. E., et al. (2001) · Neurology · doi:10.1212/wnl.56.7.843 · Cited by 212 · see citing works
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
Cudkowicz, M., Shefner, J. M., Schoenfeld, D., Brown, R. H., Jr., Johnson, H., Qureshi, M., Jacobs, M., Rothstein, J. D., Appel, S. H., Pascuzzi, R. M., et al. (2003) · Neurology · doi:10.1212/wnl.61.4.456 · Cited by 203 · see citing works
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis
Miller, R. G., Moore, D., Young, L., Armon, C., Barohn, R. J., Bromberg, M. B., Bryan, W. W., Gelinas, D. F., Mendoza, M. C., Neville, H. E., et al. (1996) · Neurology · doi:10.1212/wnl.47.6.1383 · Cited by 152 · see citing works
Gordon, P. H., Miller, R. G., & Moore, D. H. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/17434470410019906 · Cited by 109 · see citing works
Self-citationA two-stage design for a phase II clinical trial of coenzyme Q10 in ALS
Levy, G., Kaufmann, P., Buchsbaum, R., Montes, J., Barsdorf, A. I., Arbing, R. H. A., Battista, V., Zhou, X., Mitsumoto, H., Levin, B., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000201182.60750.66 · Cited by 98 · see citing works
Self-citationRating the severity of ALS by caregivers over the telephone using the ALSFRS‐R
Kasarskis, E. J., Dempsey‐Hall, L., Thompson, M. M., Luu, L. C. T., Mendiondo, M. S., & Kryscio, R. J. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510027107 · Cited by 69 · see citing works
Inter-evaluator reliability of the ALS Functional Rating Scale
Miano, B., Stoddard, G. J., Davis, S., & Bromberg, M. B. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410021302 · Cited by 48 · see citing works
A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS
Scelsa, S. N., MacGowan, D. J. L., Mitsumoto, H., Imperato, T., LeValley, A., Liu, M. H., DelBene, M., & Kim, M. Y. (2005) · Neurology · doi:10.1212/01.wnl.0000156913.24701.72 · Cited by 46 · see citing works
Self-citationBrooks, B. R. (2002) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608202320374165 · Cited by 16 · see citing works
Thompson, J. L. P., & Levy, G. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/17434470410019753 · Cited by 7 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Abrahao, A., Meng, Y., Llinas, M., Huang, Y., Hamani, C., Mainprize, T., Aubert, I., Heyn, C., Black, S. E., Hynynen, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12426-9 · Cited by 476 · see citing works
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Kaufmann, P., Thompson, J. L. P., Levy, G., Buchsbaum, R., Shefner, J. M., Krivickas, L. S., Katz, J., Rollins, Y. D., Barohn, R. J., Jackson, C. E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21743 · Cited by 236 · see citing works
Self-citationStem cell treatment in Amyotrophic Lateral Sclerosis
Mazzini, L., Mareschi, K., Ferrero, I., Vassallo, E., Oliveri, G., Nasuelli, N. A., Oggioni, G. D., Testa, L., & Fagioli, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.05.016 · Cited by 227 · see citing works
Huggins, J. E., Wren, P. A., & Gruis, K. L. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.572978 · Cited by 215 · see citing works
Nandedkar, S. D., Barkhaus, P. E., & Stålberg, E. (2010) · Muscle & Nerve · doi:10.1002/mus.21824 · Cited by 206 · see citing works
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Cudkowicz, M., Bozik, M. E., Ingersoll, E. W., Miller, R. G., Mitsumoto, H., Shefner, J. M., Moore, D. H., Schoenfeld, D., Mather, J. L., Archibald, D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2579 · Cited by 178 · see citing works
Self-citationFranchignoni, F. P., Mora, G., Giordano, A., Volanti, P., & Chiò, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304701 · Cited by 166 · see citing works
Caligari, M., Godi, M., Guglielmetti, S., Franchignoni, F. P., & Nardone, A. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.803576 · Cited by 162 · see citing works
Clinical Measures of Bulbar Dysfunction in ALS
Yunusova, Y., Plowman, E. K., Green, J. R., Barnett, C., & Bede, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00106 · Cited by 147 · see citing works
Bede, P., Bokde, A. L. W., Elamin, M., Byrne, S., McLaughlin, R. L., Jordan, N., Hampel, H. J., Gallagher, L. B., Lynch, C. M., Fagan, A. J., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302674 · Cited by 141 · see citing works
Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?
Keizman, D., Ish‐Shalom, M., Berliner, S. A., Maimon, N., Vered, Y., Artamonov, I., Tsehori, J., Nefussy, B., & Drory, V. E. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.06.002 · Cited by 133 · see citing works
Beghi, E., Chiò, A., Couratier, P., Esteban‐Pérez, J., Hardiman, O. M., Logroscino, G., Millul, A., Mitchell, D. J., Preux, P., Pupillo, E., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.502940 · Cited by 132 · see citing works
Neuwirth, C., Nandedkar, S. D., Stålberg, E., & Weber, M. (2010) · Muscle & Nerve · doi:10.1002/mus.21707 · Cited by 121 · see citing works
Emerging targets and treatments in amyotrophic lateral sclerosis
Zinman, L. H., & Cudkowicz, M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70024-2 · Cited by 109 · see citing works
Watanabe, H., Atsuta, N., Nakamura, R., Hirakawa, A., Watanabe, H., Ito, M., Senda, J., Katsuno, M., Izumi, Y., Morita, M., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.990036 · Cited by 95 · see citing works
Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis
Shellikeri, S., Green, J. R., Kulkarni, M., Rong, P., Martino, R., Zinman, L. H., & Yunusova, Y. (2016) · Journal of Speech Language and Hearing Research · doi:10.1044/2016_jslhr-s-15-0238 · Cited by 93 · see citing works
Maier, A., Holm, T., Wicks, P. J., Steinfurth, L., Linke, P., Münch, C., Meyer, R., & Meyer, T. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.633268 · Cited by 87 · see citing works
Allison, K. M., Yunusova, Y., Campbell, T. F., Wang, J., Berry, J. D., & Green, J. R. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1303515 · Cited by 87 · see citing works
Neuwirth, C., Barkhaus, P. E., Burkhardt, C., Castro, J., Czell, D., de Carvalho, M. A., Nandedkar, S. D., Stålberg, E., & Weber, M. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.11.026 · Cited by 84 · see citing works
Kim, H. Y., Kim, H., Oh, K., Oh, S., Koh, S., Baik, W., Noh, M., Kim, K. S., & Kim, S. H. (2014) · Stem Cells · doi:10.1002/stem.1770 · Cited by 83 · see citing works
Stipancic, K. L., Yunusova, Y., Berry, J. D., & Green, J. R. (2018) · Journal of Speech Language and Hearing Research · doi:10.1044/2018_jslhr-s-17-0366 · Cited by 83 · see citing works
Fournier, C. N., Bedlack, R., Quinn, C. C., Russell, J., Beckwith, D., Kaminski, K. H., Tyor, W. R., Hertzberg, V., James, V., Polak, M. A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4490 · Cited by 82 · see citing works
Schuster, C., Kasper, E., Machts, J., Bittner, D., Kaufmann, J., Benecke, R., Teipel, S. J., Vielhaber, S., & Prudlo, J. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7083-z · Cited by 82 · see citing works
Measuring function in advanced ALS: validation of ALSFRS‐EX extension items
Wicks, P. J., Massagli, M. P., Wolf, C., & Heywood, J. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02434.x · Cited by 82 · see citing works
Outcome measures in amyotrophic lateral sclerosis clinical trials
Paganoni, S., Cudkowicz, M., & Berry, J. D. (2014) · Clinical Investigation · doi:10.4155/cli.14.52 · Cited by 70 · see citing works
Bakker, L. A., Schröder, C. D., Tan, H. H. G., Vugts, S. M. A. G., van Eijk, R. P. A., van Es, M. A., Visser‐Meily, J. M. A., & van den Berg, L. H. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321138 · Cited by 70 · see citing works
Oskoui, M., & Kaufmann, P. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.007 · Cited by 69 · see citing works
Self-citationFranchignoni, F. P., Mandrioli, J., Giordano, A., Ferro, S., & ERRALS Group (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1026829 · Cited by 68 · see citing works
Patterns of Spontaneous Brain Activity in Amyotrophic Lateral Sclerosis: A Resting-State fMRI Study
Luo, C., Chen, Q., Huang, R., Chen, X., Chen, K., Huang, X., Tang, H., Gong, Q., & Shang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045470 · Cited by 68 · see citing works
Neuwirth, C., Braun, N., Claeys, K. G., Bucelli, R. C., Fournier, C. N., Bromberg, M. B., Petri, S., Goedee, H. S., Lenglet, T., Leppanen, R. E., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.04.614 · Cited by 66 · see citing works
Guedes, K., Pereira, C., Pavan, K., & Valério, B. C. O. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000100010 · Cited by 64 · see citing works
Clinical Outcome Measures in Spinal Muscular Atrophy
Montes, J., Gordon, A. M., Pandya, S., Vivo, D. C. D., & Kaufmann, P. (2009) · Journal of Child Neurology · doi:10.1177/0883073809332702 · Cited by 62 · see citing works
Self-citationClinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
Rutkove, S. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0331-9 · Cited by 59 · see citing works
Andrews, J. A., Berry, J. D., Baloh, R. H., Carberry, N., Cudkowicz, M. E., Dedi, B., Glass, J., Maragakis, N. J., Miller, T. M., Paganoni, S., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26989 · Cited by 57 · see citing works
Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy
ERRALS Group, Mandrioli, J., Biguzzi, S., Guidi, C., Sette, E., Terlizzi, E., Ravasio, A., Casmiro, M., Salvi, F., Liguori, R., et al. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2343-6 · Cited by 58 · see citing works
Bakker, L. A., Schröder, C. D., van Es, M. A., Westers, P., Visser‐Meily, J. M. A., & van den Berg, L. H. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8538-4 · Cited by 58 · see citing works
Capozzo, R., Zoccolella, S., Musio, M., Barone, R., Accogli, M., & Logroscino, G. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1773502 · Cited by 57 · see citing works
Amyotrophic lateral sclerosis patients' self‐reported satisfaction with assistive technology
Gruis, K. L., Wren, P. A., & Huggins, J. E. (2011) · Muscle & Nerve · doi:10.1002/mus.21951 · Cited by 55 · see citing works
Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses
Gladman, M., Dharamshi, C., & Zinman, L. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.932382 · Cited by 54 · see citing works
Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients
Nakamura, R., Atsuta, N., Watanabe, H., Hirakawa, A., Watanabe, H., Ito, M., Senda, J., Katsuno, M., Tanaka, F., Izumi, Y., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306020 · Cited by 52 · see citing works
Abdulla, S., Vielhaber, S., Körner, S., Machts, J., Heinze, H., Dengler, R., & Petri, S. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6955-6 · Cited by 49 · see citing works
Kovalchuk, M. O., Heuberger, J. A. A. C., Sleutjes, B. T. H. M., Ziagkos, D., van den Berg, L. H., Ferguson, T. A., Franssen, H., & Groeneveld, G. J. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1096 · Cited by 48 · see citing works
Maier, A., Boentert, M., Reilich, P., Witzel, S., Petri, S., Großkreutz, J., Metelmann, M., Lingor, P., Cordts, I., Dorst, J., et al. (2022) · Neurological Research and Practice · doi:10.1186/s42466-022-00224-6 · Cited by 46 · see citing works
The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis
Christidi, F., Karavasilis, E., Velonakis, G., Ferentinos, P. P., Rentzos, M., Kelekis, N., Evdokimidis, I., & Bede, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00523 · Cited by 46 · see citing works
Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort
Walt, G. S., Burris, H. M., Brady, C. B., Spencer, K. R., Alvarez, V. E., Huber, B. R., Guilderson, L., Abdul Rauf, N., Collins, D., Singh, T., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly092 · Cited by 45 · see citing works
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression ofTTN
Watanabe, H., Atsuta, N., Hirakawa, A., Nakamura, R., Nakatochi, M., Ishigaki, S., Iida, A., Ikegawa, S., Kubo, M., Yokoi, D., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311541 · Cited by 43 · see citing works
Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis
Wolfe, G. I., Barohn, R. J., Sanders, D. B., & McDermott, M. P. (2008) · Muscle & Nerve · doi:10.1002/mus.21142 · Cited by 39 · see citing works
Bacci, E. D., Staniewska, D., Coyne, K. S., Boyer, S., White, L. A., Zach, N., Cedarbaum, J. M., & The Pooled Resource Open-Access ALS Clinical Trials Consortium (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1095930 · Cited by 39 · see citing works
Green, J. R., Allison, K. M., Cordella, C., Richburg, B. D., Pattee, G. L., Berry, J. D., Macklin, E. A., Pioro, E. P., & Smith, R. A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13745 · Cited by 39 · see citing works
A plug-and-play brain-computer interface to operate commercial assistive technology
Thompson, D. E., Gruis, K. L., & Huggins, J. E. (2013) · Disability and Rehabilitation Assistive Technology · doi:10.3109/17483107.2013.785036 · Cited by 37 · see citing works
Macchi, Z. A., Wang, Y., Moore, D. H., Katz, J., Saperstein, D., Walk, D., Simpson, E. P., Genge, A. L., Bertorini, T. E., Fernandes, J. A., et al. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1026826 · Cited by 36 · see citing works
Qualitative measures that assess functional disability and quality of life in ALS
Hartmaier, S. L., Rhodes, T., Cook, S. F., Schlusser, C. L., Chen, C., Han, S., Zach, N., Murthy, V., & Davé, S. (2022) · Health and Quality of Life Outcomes · doi:10.1186/s12955-022-01919-9 · Cited by 37 · see citing works
JaCALS, Yokoi, D., Atsuta, N., Watanabe, H., Nakamura, R., Hirakawa, A., Ito, M., Watanabe, H., Katsuno, M., Izumi, Y., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8109-0 · Cited by 37 · see citing works
Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale
Mitsumoto, H., Chiuzan, C. C., Gilmore, M., Zhang, Y., Simmons, Z., Paganoni, S., Kisanuki, Y. Y., Zinman, L. H., Jawdat, O., Sorenson, E. J., et al. (2019) · Muscle & Nerve · doi:10.1002/mus.26765 · Cited by 36 · see citing works
Self-citationElektive Termination der Beatmungstherapie bei der amyotrophen Lateralsklerose
Meyer, T., Dullinger, J. S., Münch, C., Keil, J., Hempel, E., Rosseau, S., Borisow, N., & Linke, P. (2008) · Der Nervenarzt · doi:10.1007/s00115-008-2439-9 · Cited by 36 · see citing works
Meyer, T., Spittel, S., Grehl, T., Weyen, U., Steinbach, R., Kettemann, D., Petri, S., Weydt, P., Günther, R., Baum, P., et al. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2104649 · Cited by 35 · see citing works
Wong, C., Dakin, R. S., Williamson, J., Newton, J. L., Steven, M., Colville, S., Stavrou, M., Gregory, J. M., Elliott, E., Mehta, A. R., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064173 · Cited by 34 · see citing works
Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials
Govindarajan, R., Berry, J. D., Paganoni, S., Pulley, M., & Simmons, Z. (2020) · Muscle & Nerve · doi:10.1002/mus.26921 · Cited by 31 · see citing works
Montes, J., Eichinger, K. J., Pasternak, A. E., Kanner, C. H., & Krosschell, K. J. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02165-w · Cited by 28 · see citing works
Self-citationGrimaldi, S., Duprat, L., Grapperon, A., Verschueren, A., Delmont, É., & Attarian, S. (2017) · Muscle & Nerve · doi:10.1002/mus.25595 · Cited by 28 · see citing works
Ladha, S., Chibnik, L., Quintana, M., Wang, J., Macklin, E., Saville, B., Detry, M., Vestrucci, M., Paulon, G., McGlothlin, A., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00173-5 · Cited by 26 · see citing works
Fournier, C. N., James, V., & Glass, J. D. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2153607 · Cited by 26 · see citing works
Outcome measures for early phase clinical trials
Gordon, P. H., Cheng, B., Montes, J., Doorish, C., Albert, S. M., & Mitsumoto, H. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701547958 · Cited by 25 · see citing works
Self-citationZeissler, M., Li, V., Parmar, M., & Carroll, C. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191856 · Cited by 24 · see citing works
Multidisciplinary ALS clinics in the USA: A comparison of those who attend and those who do not
Stephens, H., Felgoise, S. H., Young, J., & Simmons, Z. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.994530 · Cited by 24 · see citing works
A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis
Pathak, S., Caress, J. B., Wosiski‐Kuhn, M., Milligan, C., Williams, D., & Cartwright, M. S. (2018) · Muscle & Nerve · doi:10.1002/mus.26360 · Cited by 23 · see citing works
Wills, A.-M. A., Garry, J., Hubbard, J. L., Mezoian, T., Breen, C. T., Ortiz-Miller, C., Nalipinski, P., Sullivan, S. L., Berry, J. D., Cudkowicz, M., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1330-6 · Cited by 22 · see citing works
The future of ALS diagnosis and staging: where do we go from here?
Genge, A. L., & Chiò, A. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2150555 · Cited by 21 · see citing works
Designing Clinical Trials in Amyotrophic Lateral Sclerosis
Shefner, J. M. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.02.002 · Cited by 21 · see citing works
Enhancing clinical trials in neurodegenerative disorders
Gladman, M., Cudkowicz, M., & Zinman, L. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a309d · Cited by 20 · see citing works
Seeking a measure of clinically meaningful change in ALS
McElhiney, M. C., Rabkin, J. G., Goetz, R. R., Katz, J., Miller, R. G., Forshew, D. A., David, W., Cudkowicz, M., Glass, J. D., Appel, S. H., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.942668 · Cited by 20 · see citing works
Self-citationHamidou, B., Marin, B., Lautrette, G., Nicol, M., Camu, W., Corcia, P., Arné‐Bes, M., Tranchant, C., Clavelou, P., Hannequin, D., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1353098 · Cited by 20 · see citing works
Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans
Spencer, K. R., Foster, Z. W., Rauf, N. A., Guilderson, L., Collins, D., Averill, J. G., Walker, S. E., Robey, I., Cherry, J. D., Alvarez, V. E., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12876 · Cited by 19 · see citing works
Verdiperstat in Amyotrophic Lateral Sclerosis
Hayden, D., Lai, P.-Y., Donahue, R. A., Chen, H.-W., Wang, J., Mathai, N. M., Lopes, G., McCaffrey, A., Scalia, J., Luppino, S. D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2024.5249 · Cited by 18 · see citing works
Al‐Chalabi, A., Shaw, P. J., Young, C. A., Morrison, K. E., Murphy, C., Thornhill, M., Kelly, J., Steen, I. N., & Leigh, P. N. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-111 · Cited by 18 · see citing works
Atassi, N., Schoenfeld, D., & Cudkowicz, M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139032445.025 · Cited by 17 · see citing works
Identification of Personal Factors in Motor Neurone Disease: A Pilot Study
Ng, L., & Khan, F. (2011) · Rehabilitation Research and Practice · doi:10.1155/2011/871237 · Cited by 16 · see citing works
Erb, M. K., Calcagno, N., Brown, R. Z., Burke, K. M., Scheier, Z. A., Iyer, A. S., Clark, A., Higgins, M., Keegan, M., Gupta, A. S., et al. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2322549 · Cited by 15 · see citing works
Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R
Jackson, C. E., de Carvalho, M. A., Genge, A. L., Heiman-Patterson, T. D., Shefner, J. M., Wei, J., & Wolff, A. A. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1497658 · Cited by 15 · see citing works
Amyotrophic Lateral Sclerosis in Korea: Clinical Characteristics and Prognostic Factors
백원기, 박아람, Kim, H., & Kim, S. H. (2011) · Journal of the Korean Neurological Association · Cited by 13 · see citing works
Ng, L., & Khan, F. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2011.606345 · Cited by 12 · see citing works
James, N., Power, E., Hogden, A., & Vucic, S. (2018) · Disability and Rehabilitation Assistive Technology · doi:10.1080/17483107.2018.1499139 · Cited by 12 · see citing works
Haji, S., Fujita, K., Oki, R., Osaki, Y., Miyamoto, R., Morino, H., Nagano, S., Atsuta, N., Kanazawa, Y., Matsumoto, Y., et al. (2022) · JMIR Research Protocols · doi:10.2196/42032 · Cited by 11 · see citing works
Jin, J., Hu, F., Zhang, Q., Chen, Q. Y., Li, H., Qin, X., Jia, R., Li, K., Dang, Y., & Dang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-56665-8 · Cited by 11 · see citing works
Non-self-sufficiency as a primary outcome measure in ALS trials
Marin, B., Bianchi, E., Pupillo, E., Lunetta, C., Tremolizzo, L., Logroscino, G., Chiò, A., Preux, P., & Beghi, E. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1074704 · Cited by 11 · see citing works
Validation of the Italian version of self-administered ALSFRS-R scale
Manera, U., Cabras, S., Daviddi, M., Vasta, R., Torrieri, M. C., Palumbo, F., Bombaci, A., Grassano, M., Solero, L., Peotta, L., et al. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1813307 · Cited by 11 · see citing works
Iranian clinical practice guideline for amyotrophic lateral sclerosis
Boostani, R., Olfati, N., Shamshiri, H., Salimi, Z., Fatehi, F., Hedjazi, S. A., Fakharian, A., Ghasemi, M., Okhovat, A. A., Basiri, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1154579 · Cited by 10 · see citing works
Plewa, J., Surampalli, A., Wencel, M., Milad, M., Donkervoort, S. C., Caiozzo, V. J., Goyal, N., Mozaffar, T., & Kimonis, V. E. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.06.007 · Cited by 10 · see citing works
Chinese validation of the Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disability Scale
Sun, C., Fournier, C. N., Ye, S., Zhang, N., Ma, Y., & Fan, D. (2021) · European Journal of Neurology · doi:10.1111/ene.14811 · Cited by 10 · see citing works
Clinical Trials in Progressive Neurological Diseases
Bedlack, R., & Cudkowicz, M. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000209493 · Cited by 10 · see citing works
Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes
Lechtzin, N., Maragakis, N. J., Kimball, R., Busse, A. M., Hoffman, V., & Clawson, L. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802502993 · Cited by 10 · see citing works
Commentary: Measuring what matters: the case for patient generated PROMS
Wicks, P. J. (2015) · BMJ · doi:10.1136/bmj.h54 · Cited by 10 · see citing works
Yamamoto, M., Tanaka, F., Tatsumi, H., & Sobue, G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.11.1845 · Cited by 9 · see citing works
Steinfurth, L., Grehl, T., Weyen, U., Kettemann, D., Steinbach, R., Rödiger, A., Großkreutz, J., Petri, S., Boentert, M., Weydt, P., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2468404 · Cited by 8 · see citing works
Newton, J. L., Jayaprakash, K., Glasmacher, S. A., McEleney, A., Bethell, A., Fraser, E., Hatrick, J., Haagenrud, H., Stott, G., Dakin, R. S., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116991 · Cited by 8 · see citing works
Neuropsychological sequelae in motor neurone disease: outcomes of a peer support programme
Ng, L., Talman, P. S., & Khan, F. (2011) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2011.18.8.429 · Cited by 7 · see citing works
Patient/carer perceptions of disability in motor neurone disease and carer coping
Ng, L., Kee, K., Amatya, B., & Khan, F. (2011) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2011.18.10.568 · Cited by 7 · see citing works
Estimating the minimum important difference in the ALSFRS-R-instrument in people living with MND
Boddy, S. L., Simpson, R. M., Walters, S. J., Bamford, H., Walsh, T., McDermott, C. J., PROSEC3 STUDY GROUP, Christopher, M., Chhetri, S. K., Turner, M. R., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2447916 · Cited by 6 · see citing works
A Review of Clinical Trial Designs in Amyotrophic Lateral Sclerosis
Moore, D. H., Katz, J., & Miller, R. G. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.70 · Cited by 6 · see citing works
Montes, J., Bendotti, C., Tortarolo, M., Cheroni, C., Hallak, H., Speiser, Z., Goren, S., Blaugrund, E., & Gordon, P. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00019-9 · Cited by 6 · see citing works
Self-citation
- Authors
- Kaufmann, P., Levy, G., Montes, J., Buchsbaum, R., Barsdorf, A. I., Battista, V., Arbing, R., Gordon, P. H., Mitsumoto, H., Levin, B., Thompson, J. L. P., Kaufmann, P., Levy, G., Montes, J., Buchsbaum, R., Barsdorf, A. I., Battista, V., Arbing, R., Gordon, P. H., Mitsumoto, H., Levin, B., & Thompson, J. L. P.
- Venue
- Amyotrophic Lateral Sclerosis
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 8
- Issue
- 1
- Pages
- 42-46
- ISSN
- 1471-180X (ISSN-L)
- 1748-2968
- OpenAlex
- W2022387525
- Cited by
- 145
- References
- 23
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 13 · 2021: 2 · 2020: 10 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 7 · 2013: 8 · 2012: 7
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Amyotrophic Lateral Sclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01 NS48555, R01 NS 48125, R01NS048125, R01NS048555)
- National Center for Research Resources (M01 RR00109, M01RR001066, M01RR000109, K12RR017648, M01-RR01066)
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- ALSFRS-R, functional rating scale, inter-rater reliability, intra-rater reliability, telephone administration, outcome measure reliability
- MeSH terms
- Activities of Daily Living, Amyotrophic Lateral Sclerosis, Coenzymes, Double-Blind Method, Humans, Retrospective Studies, Severity of Illness Index, Telephone, Ubiquinone, Vitamins, Reproducibility of Results, Caregivers, Sickness Impact Profile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review